UPenn Hepatitis Grand Rounds - Home Page

 

HepGrandRounds19_Theme_Banner_v3

Jointly Sponsored by: Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc.
 

HEP_19_LiveSeries_button
 

About the Program

Program Overview

The Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc. are proud to present the "Hepatitis Grand Rounds" 2019 series. Formerly the "Viral Hepatitis Grand Rounds", this program is modeled on the ground-breaking CME activity "HIV Grand Rounds," which, in partnership with the Perelman School of Medicine at the University of Pennsylvania, is currently in its tenth year. These CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The  Hepatitis Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania is delivered live via the Internet on two Wednesdays each month at 12:00 pm Eastern Time and each presentation is available for on-demand viewing immediately following the live broadcast.

Hepatitis Grand Rounds presentations cover the most important and current topics in hepatitis, including NASH, HBV and HCV, and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing clinicians and many are case-based. The final 10 minutes of each one-hour educational activity consists of a live question and answer period, with the presenting faculty member available to answer questions asked by attendees using the webinar interface. These bi-monthly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their hepatitis patients.

Each session may be broadcast via your Internet connection in your conference room or auditorium for large groups to view, or individually to your personal computer at your convenience. Simply register at www.viraled.com/hepatitisgrandrounds for easy access.


 
Back to Top

Target Audience

This program has been designed for Family Medicine, Pediatrics, Neurology, Obstetrics And Gynecology, Psychiatry, Internal Medicine - Endocrinology, Diabetes And Metabolism, Internal Medicine - Gastroenterology, Internal Medicine - Infectious Disease, Internal Medicine - Transplant Hepatology

Back to Top

Commercial Support Acknowledgement

Hepatitis Grand Rounds is supported by educational grants from Gilead Sciences Medical Affairs and Intercept Pharmaceuticals, Inc.

Back to Top

Learning Objectives

After completing this activity, participants should be better able to:

  • Demonstrate increased understanding of the epidemiology of and risk factors for viral hepatitis and NASH
  • Increase the rate of testing of viruses and other conditions associated with hepatitis, such as NASH 
  • Demonstrate improved knowledge, competence and clinical practice in terms of the current standards and guidelines for the management of patients with viral and non-viral hepatitis, including those with NASH
  • Demonstrate an improved understanding of the treatment of hepatitis in patients co-infected with HIV or other viral infections
Back to Top

Course Directors

David E. Kaplan, MD, MSc
Associate Professor of Medicine
Division of Gastroenterology
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

K. Rajender Reddy, MD
Ruimy Family President's Distinguished Professor of Medicine
Professor of Medicine in Surgery
Director of Hepatology
Director, Viral Hepatitis Center
Medical Director, Liver Transplantation

Raymond Soccio, MD
Assistant Professor of Medicine
Division of Endocrinology, Diabetes and Metabolism
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

Next Session and Participation Information

Presented live at 12:00 PM ET, bi-weekly on Wednesdays and anytime On-Demand

  • Delivered via webinar directly to you  and/or your clinic
  • You, or your clinic's coordinator, will receive a weekly email with topic, speaker and webinar link
  • Sessions can be viewed in a large conference room or auditorium for large group viewing and participation, or directly on your personal computer, tablet or smart device

If CME credit is desired for any of the live sessions, proceed to https://upenn.cloud-cme.com to create your personal CME account. After your account is established this one time, following each session simply text the session code listed in the presentation slides to receive your CME credit.

Back to Top

Live Session Topics and Speakers


February 13, 2019

2019 Hepatitis Grand Rounds Preview/Cases

David Kaplan, MD and Raymond Soccio, MD

Click HERE to View ON-DEMAND


February 27, 2019

Hepatitis C:  Treatment in Primary Care and Resource-limited settings

Shyam Kottilil, MD, PhD

Click HERE to View On-Demand 


March 13, 2019

Update on the Use of Hepatitis C-infected Organs in Solid Organ Transplantation

David Goldberg, MD

Click HERE to View On-Demand


March 27, 2019

Transforming the Treatment Landscape for Hepatic Fibrosis and NASH – Principles and Progress

Scott Friedman, MD

Click HERE to View On-Demand


April 17, 2019

Weight management and anti-diabetic drugs in patients with NAFLD and other chronic liver diseases

Raymond Soccio, MD

Click HERE to Register 


April 24, 2019

Update on CROI 2019

Susanna Naggie, MD

Click HERE to Register 


May 8, 2019

Update on EASL 2019

Mark Sulkowski, MD

Click HERE to Register 


May 22, 2019

Stacey Prenner, MD

Real Cases from the University of Pennsylvania

Click HERE to Register 


June 5, 2019

Lipid issues and Cardiac Disease associated with NAFLD

Rotonya Carr, MD

Click HERE to Register 


June 19, 2019

Evolving Trends for Managing Viral Hepatitis in Liver Transplantation

Elizabeth Verna, MD, MS

Click HERE to Register 


October 2, 2019

TBD

TBD

Click HERE to Register 


October 16, 2019

Novel Therapies for Fatty Liver and NASH

Stephen Harrison, MD

Click HERE to Register 


October 30, 2019

Non-Invasive Diagnosis and Staging of NAFLD

Rohit Loomba, MD, MHSc

Click HERE to Register 


November 13, 2019

Global Elimination of Viral Hepatitis

Prof. Gregory Dore

Click HERE to Register 


 

November 20, 2019

Update on AASLD 2019

Mark Sulkowski, MD

Click HERE to Register 


December 4, 2019

TBD

TBD

Click HERE to Register 


 
 

Back to Top

Hardware/Software Notice

You will need Internet to participate in this activity.

Accreditation

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation of Credit

Physicians: Penn Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Nurses/Pharmacists: This activity is not approved for nursing or pharmacy contact hours

PAs: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.00 Category 1 credits for completing this activity.

Disclosure of Relevant Financial Relationships and Unapproved Uses of Products

It is policy at Penn Medicine Office of Continuing Medical and Interprofessional Education for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provide products or services that may be relevant to the content of this continuing education activity.  For this purpose, we consider relationships of the person involved to include financial relationships of a spouse or partner.

The intent of this policy is to ensure that Penn CME/CE certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information was found to contain relationships that created a conflict of interest relevant to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.

The staff in the Office of Continuing Medical and Interprofessional Education (CME and IPCE), Mila Kostic, CHCP, FACEHP, Director of CME and Co-Director of IPCE Penn Medicine, Zalman Agus, MD, Senior Peer Reviewer and Patricia A. Smith, DNP, RN-BC, Penn IPCE Lead Nurse Planner have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity.

The following faculty or planning committee members have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:

Planning Committee Members:

  • Program Co-Chair: Raymond Soccio, MD
  • ViralEd, Inc.: Brian Boyle, MD; Oliver Fultz; Rick Gordon
  • UPenn CME: Mila Kostic, CHCP, FACEHP

The following faculty or planning committee members have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity:


David Kaplan, MD (Program Co-Chair)

  • Grant/Research Support Recipient: Gilead; Bayer Corporation

K. Rajender Reddy, MD (Program Co-Chair)

  • Advisor or Review Panel Member: Gilead; Merck & Co.; Abbvie; Dova; Shionogi; Spark Therapeutics; Novartis AG; 
  • Grant/Research Support Recipient: Merck & Co.; Abbvie; Intercept; Conatus; Mallinckrodt; Exact Sciences
Back to Top

Discussion of Investigational and/or Off-label Use of Commercial Products and Devices

The Perelman School of Medicine at the University of Pennsylvania requires all faculty to disclose any discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside DA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.

Faculty members will disclose to participants any discussions of off-label and/or investigational uses of pharmaceutical products within their presentations.

Back to Top

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

   

    UPenn CME - 2019          VE Logo 2019           

     



 

 

Back to Top

 

Prepare to print

Share this page:

Get link code to this page                     


Back to Top